Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Cysltr1 - 4T1 breast cancer model: metastatic sub-populations
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Cysltr1 - Spleen response to acute LCMV-Armstrong and persistent LCMV-Clone13 infections: time course
Cysltr1 - Nitric oxide generator DETA-NONOate effect on in vitro neuronal injury model: time course
Cysltr1 - All-trans retinoic acid effect on retinoic acid receptor α-deficient F9 teratocarcinoma cells
Cysltr1 - Liver response to Pacific ciguatoxin-1: time course
Cysltr1 - Glomerulonephropathy
Cysltr1 - In vitro-differentiated CD4+ T helper cell subsets
Cysltr1 - Retinoic acid effect on CD4+ T cells from spleen/lymph nodes
Cysltr1 - Cytotoxic T cell line response to interleukin-2: time course
Cysltr1 - Chronic, low level drug exposure effect on obese liver
Cysltr1 - Atherosclerosis susceptibility model: macrophages
Cysltr1 - FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Cysltr1 - Wnt4 mutation effect on female embryonic gonads
Cysltr1 - Lipopolysaccharide-stimulated, NFκB ζ inhibitor (IκBζ) deficient-peritoneal macrophages
Cysltr1 - Regulatory, pathogenic and control CD4+ T cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on